ALCAM is also associated with tamoxifen resistance in breast cancer cells, and ALCAM knockdown substantially enhances tamoxifen-induced cancer cell viability inhibition and apoptosis (Chen et al., 2017). This evidence concerns the gene ALCAM and breast cancer.